Literature DB >> 5771673

Use of cuprous thiocyanate as a short-term continuous marker for faeces.

M Dick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5771673      PMCID: PMC1552857          DOI: 10.1136/gut.10.5.408

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  EXPERIENCES WITH THE USE OF INTERRUPTED CARMINE RED AND CONTINUOUS CHROMIUM SESQUIOXIDE MARKING OF HUMAN FAECES WITH REFERENCE TO CALCIUM, PHOSPHORUS, AND MAGNESIUM.

Authors:  G A ROSE
Journal:  Gut       Date:  1964-06       Impact factor: 23.059

2.  Experience with the chromic oxide method of fecal marking in metabolic balance investigations on humans.

Authors:  L G WHITBY; D LANG
Journal:  J Clin Invest       Date:  1960-06       Impact factor: 14.808

3.  An improved colorimetric enzymatic assay of ceruloplasmin.

Authors:  H A RAVIN
Journal:  J Lab Clin Med       Date:  1961-07

4.  The determination of thiocyanate in blood serum.

Authors:  R G Bowler
Journal:  Biochem J       Date:  1944       Impact factor: 3.857

5.  Use of barium sulphate as a continuous marker for faeces.

Authors:  M Dick
Journal:  J Clin Pathol       Date:  1967-03       Impact factor: 3.411

  5 in total
  12 in total

1.  Zinc and di-iodohydroxyquinoline therapy in acrodermatitis enteropathica.

Authors:  M J Jackson
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

2.  Quantitative analysis of single stool samples using a continuous marker.

Authors:  T Gilat; O Ronen
Journal:  Am J Dig Dis       Date:  1972-08

3.  Estimation of faecal fat excretion using cuprous thiocyanate as a continuous marker.

Authors:  M F Lee; J M Temperley; M Dick
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

4.  Possible prevention and treatment of steroid-induced osteoporosis.

Authors:  J R Condon; J R Nassim; C E Dent; A Hilb; E M Stainthorpe
Journal:  Postgrad Med J       Date:  1978-04       Impact factor: 2.401

5.  Assessment of fat malabsorption.

Authors:  L B Teh; M Stopard; S Anderson; A Grant; D Quantrill; R H Wilkinson; D P Jewell
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

6.  Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs.

Authors:  T C Stamp; J M Round; D J Rowe; J G Haddad
Journal:  Br Med J       Date:  1972-10-07

7.  Radio-opaque pellets as faecal markers for faecal fat estimation in malabsorption.

Authors:  F G Simpson; G P Hall; J Kelleher; M S Losowsky
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

8.  Polyethylene glycol 4000 as a continuously administered non-absorbable faecal marker for metabolic balance studies in human subjects.

Authors:  R Wilkinson
Journal:  Gut       Date:  1971-08       Impact factor: 23.059

9.  The 14C-glycocholate test in diabetic diarrhoea.

Authors:  J H Scarpello; R V Hague; D R Cullen; G E Sladen
Journal:  Br Med J       Date:  1976-09-18

10.  Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?

Authors:  J A Kanis; T Cundy; M Bartlett; R Smith; G Heynen; G T Warner; R G Russell
Journal:  Br Med J       Date:  1978-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.